Detailing Hedgehog-Signalling Inhibition as a Promising Target for Unmet Needs in the Dermatology Universe
Time: 3:30 pm
day: Day One
Details:
• Exploring the mechanism of Patidegib a hedgehog inhibitor (HHI) blocker, preventing new basal cell carcinomas in Gorlin Syndrome
• Current data showcasing the potential of this mechanism and highlighting the benefits of topical HHIs over oral HHIs
